UBS Mergers and Acquisitions Presentation Deck

Financial overview of the combined entity TBVPS Target EPS Costs ROCET1 Day-1 CET1 ratio Capital return policy UBS - - 74% increase at Day-1 EPS accretive by 2027 Run-rate annual cost reduction of >8bn, by 2027 ROCET1 impacted by integration and restructuring in the near- and medium-term Significantly above our -13% target CHF ~56bn full badwill recognition (including equity from AT1 write-down) to count towards CET1 capital to cover both purchase accounting marks, restructuring costs and acceleration of non-core assets run-down Remaining committed to a progressive cash dividend; temporarily suspending share repurchases 5

View entire presentation